Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations
- PMID: 1701635
- DOI: 10.1016/s0006-291x(05)81050-2
Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations
Abstract
A method for the preparation of 57Co-labelled bleomycin (BLM) possessing very high specific radioactivity and suitable for use at the nanomolar concentration range is described, and validated using a biological assay. Chelation of BLM with Co(II) results in a very stable complex. However, association does not occur below the micromolar concentration range. A nanomolar [57Co]BLM solution with maximal specific radioactivity can be easily prepared, without handling unreasonable amounts of radioactivity, provided that: equimolar solutions of BLM and [57Co]Cl2 are first mixed at the micromolar concentration range and that the mixture is then diluted a thousand times to reach the nanomolar concentration range.
Similar articles
-
Intracellular distribution of 57Co-bleomycin.Curr Top Radiat Res Q. 1978 Jan;12(1-4):497-512. Curr Top Radiat Res Q. 1978. PMID: 76527
-
Labelled bleomycin as a tumour-localizing agent. II. The effect of dose loading of the different forms of 57Cobalt-bleomycin A2, B2, and pepleomycin on the tissue distribution and tumour uptake in tumour-bearing rats.Eur J Nucl Med. 1982;7(2):92-4. doi: 10.1007/BF00251652. Eur J Nucl Med. 1982. PMID: 6177534
-
57Co-bleomycin imaging study of tumors of the head and neck.Laryngoscope. 1978 Jun;88(6):1013-8. doi: 10.1288/00005537-197806000-00013. Laryngoscope. 1978. PMID: 77463
-
Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.Eur J Nucl Med. 1983;8(12):535-40. doi: 10.1007/BF00251616. Eur J Nucl Med. 1983. PMID: 6199207
-
The influence of chemotherapy on the distribution of 57Co-bleomycin in chemically induced squamous cell carcinoma of mouse skin.Eur J Nucl Med. 1979 Feb 1;4(1):55-9. doi: 10.1007/BF00257571. Eur J Nucl Med. 1979. PMID: 91511
Cited by
-
Comparative roles of the cell wall and cell membrane in limiting uptake of xenobiotic molecules by Saccharomyces cerevisiae.Antimicrob Agents Chemother. 2003 Jun;47(6):2012-4. doi: 10.1128/AAC.47.6.2012-2014.2003. Antimicrob Agents Chemother. 2003. PMID: 12760888 Free PMC article.
-
Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future.Mol Biotechnol. 2009 Oct;43(2):167-76. doi: 10.1007/s12033-009-9192-6. Epub 2009 Jun 27. Mol Biotechnol. 2009. PMID: 19562526 Review.
-
Isolation and characterization of Saccharomyces cerevisiae mutants with enhanced resistance to the anticancer drug bleomycin.Curr Genet. 2004 May;45(5):265-72. doi: 10.1007/s00294-004-0492-x. Epub 2004 Mar 9. Curr Genet. 2004. PMID: 15007625
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources